Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Veronese SM"'
Autor:
Cairoli R, Krampera M, Zappasodi P, Todisco E, Borlenghi E, Molteni A, Fumagalli M, Ubezio M, Bernardi M, Greco Ravelli, E (Ravelli, Erika), Mancini V, Grillo G, Riva M, De Marco B, Cassaro A, Brando B, Gatti A, Veronese SM, Beghini A
Genetic and Clinical Background: The clinical outcome of Core Binding Factor Leukemia (CBFL) seems influenced by the mutational status of KIT. In fact, several retrospective studies, in addition to our own, as well as a systematic review, indicate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ad126fd279c1729f725edd93a5a263c
https://hdl.handle.net/10281/409346
https://hdl.handle.net/10281/409346
Autor:
Artale S, Sartore-Bianchi A, Veronese SM, Gambi V, Sarnataro CS, Gambacorta M, Lauricella C, Siena S
Publikováno v:
Journal of Clinical Oncology; 9/1/2008, Vol. 26 Issue 25, p4217-4219, 3p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pizzutilo EG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy. Electronic address: elio.pizzutilo@unimi.it., Agostara AG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Oresti S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Signorelli D; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Stabile S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Lauricella C; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Motta V; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Amatu A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Ruggieri L; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Brambilla M; Dipartimento di Oncologia Medica, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan., Occhipinti M; Dipartimento di Oncologia Medica, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan; Department of Experimental Medicine, Sapienza University of Rome, Rome., Proto C; Dipartimento di Oncologia Medica, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan., Giusti R; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Rome., Filetti M; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome., Genova C; UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa; Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università degli Studi di Genova, Genoa., Barletta G; UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa., Gelsomino F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Bennati C; Ospedale S. Maria delle Croci, AUSL della Romagna, Ravenna., Siringo M; Medical Oncology Department, Umberto I - Policlinico di Roma, Rome., Di Fazio GR; Department of Medical Oncology Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome., Russano M; Department of Medical Oncology Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome., Montrone M; SSD Oncologia Medica per la Patologia Toracica, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari., Gariazzo E; Medical Oncology, Santa Maria Della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia., Roca E; Thoracic Oncology - Lung Unit, P. Pederzoli Hospital, Peschiera del Garda, Verona., Bordi P; Medical Oncology Unit, University Hospital of Parma, Parma., Delmonte A; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST), Meldola (FC)., Scimone A; Medical Oncology Department, Centro Oncologico Ospedale Papardo, Messina., Belluomini L; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona., Mazzoni F; Oncology department, Careggi University Hospital - Florence., Carta A; Ospedale Oncologico A. Businco, Cagliari., Pelizzari G; Dipartimento di Oncologia, Azienda Sanitaria Universitaria Friuli Centrale, Udine., Viscardi G; Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Naples; Department of Pneumology and Oncology, AORN Ospedali dei Colli, Naples., Morgillo F; Oncologia Medica, Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Naples., Gelibter A; Medical Oncology Department, Umberto I - Policlinico di Roma, Rome., Gori S; Medical Oncology, IRCSS Sacro Cuore Don Calabria, Negrar di Valpolicella, Verona., Berardi R; Università Politecnica delle Marche - Azienda Ospedaliero Universitaria delle Marche, Ancona., Cortinovis D; SC Oncologia Medica Fondazione IRCCS San Gerardo dei Tintori, Monza., Ardizzoni A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Veronese SM; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Sartore-Bianchi A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy; Division of Clinical Research and Innovation, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Giannetta LG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Cerea G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Siena S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103592. Date of Electronic Publication: 2024 Jun 14.
Autor:
Pizzutilo EG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Agostara AG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Roazzi L; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Romanò R; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Motta V; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Lauricella C; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Marrapese G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Cerea G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Signorelli D; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Veronese SM; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Giannetta LG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Sartore-Bianchi A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy., Siena S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2023 Jul 26; Vol. 4 (11), pp. 100555. Date of Electronic Publication: 2023 Jul 26 (Print Publication: 2023).
Autor:
Antonello M; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Scutari R; Department of Experimental Medicine, University of Rome 'Tor Vergata,'Rome, Italy., Lauricella C; Department of Pathology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Renica S; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Motta V; Department of Pathology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Torri S; Unit of Microbiology, Department of Chemical-Clinical and Microbiology Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Russo C; Unit of Microbiology and Diagnostic Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Gentile L; Unit of Microbiology and Diagnostic Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Cento V; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Colagrossi L; Unit of Microbiology and Diagnostic Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Mattana G; Unit of Microbiology and Diagnostic Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Codecasa LR; Regional TB Reference Centre, Villa Marelli Institute, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Vismara C; Unit of Microbiology, Department of Chemical-Clinical and Microbiology Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Scaglione F; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Unit of Microbiology, Department of Chemical-Clinical and Microbiology Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Veronese SM; Department of Pathology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bonoldi E; Department of Pathology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bandera A; Infectious Disease Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Gori A; Infectious Disease Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Mazzola E; Unit of Microbiology, Department of Chemical-Clinical and Microbiology Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Perno CF; Unit of Microbiology and Diagnostic Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.; Multimodal Medicine Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Alteri C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Multimodal Medicine Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Publikováno v:
Frontiers in microbiology [Front Microbiol] 2021 Sep 13; Vol. 12, pp. 727774. Date of Electronic Publication: 2021 Sep 13 (Print Publication: 2021).
Autor:
Marchetti A; Laboratory of Molecular Diagnostics, Center for Advanced Studies and Technology (CAST), University of Chieti-Pescara, Italy., Barbareschi M; Department of Pathology, Santa Chiara Hospital, Trento, Italy., Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Lombardy, Italy., Buglioni S; Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Buttitta F; Laboratory of Molecular Diagnostics, Center for Advanced Studies and Technology (CAST), University of Chieti-Pescara, Italy., Fassan M; Unit of Surgical Pathology, Department of Medicine (DIMED), University of Padua.; Veneto Institute of Oncology IRCCS, Padua, Italy., Fontanini G; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy., Marchiò C; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy., Papotti M; Pathology Unit, Department of Oncology, Città Della Salute e della Scienza Hospital, University of Turin, Turin, Italy., Pruneri G; Department of Pathology and Laboratory Medicine, IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Scarpa A; Department of Diagnostics and Public Health, Section of Pathology, and ARC-Net Research Centre, University and Hospital Trust of Verona, Verona, Italy., Stanta G; DSM - Department of Medical Sciences, University of Trieste, Trieste, Italy., Tallini G; Department of Medicine (Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, DIMES), University of Bologna, Italy.; Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Troncone G; Division of Pathology, Department of Public Health, University of Naples Federico II, Naples, Italy., Veronese SM; Molecular Pathology Unit, Niguarda Hospital, Milan, Italy., Truini M; Pathological Anatomy Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Sapino A; Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy.
Publikováno v:
Pathologica [Pathologica] 2021 Aug; Vol. 113 (4), pp. 262-271.